Skip to content
    ACAD stock page

    ACADIA PHARMACEUTICALS INC

    ACAD · earnings call history

    3 calls analysed
    1. Jun 2026Q2 FY26Aug 04, 2026

      ACADIA Q2 FY26 — Strong DAYBUE and NUPLAZID Performance, Remlifanserin ADP Readout Expected

      Read the brief
    2. Mar 2026Q1 FY26May 06, 2026

      ACADIA Q1 FY26 — Strong DAYBUE Growth and Reaffirmed FY26 Guidance

      Read the brief
    3. Dec 2025Q4 FY25Feb 25, 2026

      ACADIA Q4 FY25 — Strong Commercial Performance and Pipeline Progress

      Read the brief

    Browse all US companies on the earnings-call register.